How else can you explain the share increase today?
I was getting skeptical that this would not happen again in my lifetime, but with the upward trend and long term outlook of this corporation, it could happen.
Weldon will retire in April with his $143.5 million salary + bonus.
Gorsky will assume Weldon's CEO responsibilities.
Did the Analyst at Goldman get canned?
At the very least, Weldon should be charged with crimes against the consumer, the stockholders and the J&J employees.
""Dramatic" Increase In Bleeding Accompanies Addition Of Oral Anticoagulant Therapy In ACS"
Even if J&J goes ahead with expanding uses for this drug, what about product liability law suits?
The corporation is already dealing with an excess of these suits.
For JNJ the goal line is crossing the 70 line.
For 10 years this stock has been in a funk and has lost yardage every time it tried to score at least 70.
At mid morning today it is moving closer.
My take on what I have read is that Bapineuzumab is not worth pursuing as an Alzheimer drug.
Best that can be said is that the research scientists have learned something more about the disease in their search for an effective cure.
After steering the J&J ship into near disasters, can you believe this appointment of Bill Weldon?
"Johnson & Johnson’s (NYSE:JNJ) former Chief Executive William Weldon has been named by the board of JPMorgan & Chase Co. (NYSE:JPM) as a part of a group of three directors to investigate the possible role of its Chief Executive Jamie Dimon in the “London Whale” multibillion-dollar trading blunder, according to the Wall Street Journal. The two others are Lee Raymond, former Exxon Mobil Corporation (NYSE:XOM) chairman and Chief Executive, and the real estate developer Laban Jackson."